Clinical Trials in Mechanical Circulatory Support

Heart Failure Clinics

Volumn 7, Issue 4, 2011, Pages 457-466

  Egnaczyk, Gregory ^a   Milano, Carmelo A ^a   Rogers, Joseph G ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

Bridge to transplant; Destination therapy; Left ventricular assist device; Mechanical circulatory support; Objective performance criteria

Indexed keywords

INOTROPIC AGENT; SODIUM;

ASSISTED CIRCULATION; CARDIOGENIC SHOCK; CLINICAL TRIAL (TOPIC); CONGESTIVE HEART FAILURE; DEATH; GOLD STANDARD; HEART FAILURE; HEART INDEX; HEART LEFT VENTRICLE EJECTION FRACTION; HEART TRANSPLANTATION; HUMAN; KIDNEY FAILURE; LEFT VENTRICULAR ASSIST DEVICE; MULTICENTER STUDY (TOPIC); NEUROLOGICAL COMPLICATION; PATIENT SELECTION; PROGNOSIS; PROSTHESIS FAILURE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY FAILURE; REVIEW; SEPSIS; SODIUM BLOOD LEVEL; SURVIVAL RATE; TREATMENT OUTCOME;

ASSISTED CIRCULATION; CLINICAL TRIALS AS TOPIC; EQUIPMENT DESIGN; HEART FAILURE; HUMANS; PATIENT SELECTION; TREATMENT OUTCOME;

EID: 80052935796     PISSN: 15517136     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hfc.2011.06.005     Document Type: Review

References (36)

1. Johnson M.R., Meyer K.H., Haft J., et al. Heart transplantation in the United States, 1999-2008. Am J Transplant 2010, 10:1035-1046.
2. Mancini D., Lietz K. Selection of cardiac transplantation candidates in 2010. Circulation 2010, 122:173-183.
3. Aaronson K.D., Eppinger M.J., Dyke D.B., et al. Left ventricular assist device therapy improves utilization of donor hearts. J Am Coll Cardiol 2002, 39:1247-1254.
4. Hill J.D., Farrar D.J., Hershon J.J., et al. Use of a prosthetic ventricle as a bridge to cardiac transplantion for postinfarction cardiogenic shock. N Engl J Med 1986, 314:626-628.
5. Frazier O.H., Rose E.A., Macmanus Q., et al. Multicenter clinical evaluation of the HeartMate 1000 IP left ventricular assist device. Ann Thorac Surg 1992, 53:1080-1090.
6. Frazier O.H., Rose E.A., Oz M.C., et al. Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation. J Thorac Cardiovasc Surg 2001, 122:1186-1195.
7. El-Banayosy A., Arusoglu L., Kizner L., et al. Novacor left ventricular assist system versus Heartmate vented electric left ventricular assist system as a long-term mechanical circulatory support device in bridging patients: a prospective study. J Thorac Cardiovasc Surg 2000, 119:581-587.
8. Rose E.A., Gelijns A.C., Moskowitz A.J., et al. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med 2001, 345:1435-1443.
9. Nair P.K., Kormos R.L., Teuteberg J.J., et al. Pulsatile left ventricular assist device support as a bridge to decision in patients with end-stage heart failure complicated by pulmonary hypertension. J Heart Lung Transplant 2010, 29:201-208.
10. Felker G.M., Rogers J.G. Same bridge, new destinations rethinking paradigms for mechanical cardiac support in heart failure. J Am Coll Cardiol 2006, 47:930-932.
11. Hershberger R.E., Nauman D., Walker T.L., et al. Care processes and clinical outcomes of continuous outpatient support with inotropes (COSI) in patients with refractory endstage heart failure. J Card Fail 2003, 9:180-187.
12. Rogers J.G., Butler J., Lansman S.L., et al. Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: results of the INTrEPID Trial. J Am Coll Cardiol 2007, 50:741-747.
13. Parides M.K., Moskowitz A.J., Ascheim D.D., et al. Progress versus precision: challenges in clinical trial design for left ventricular assist devices. Ann Thorac Surg 2006, 82:1140-1146.
14. Grunkemeier G.L., Jin R., Starr A. Prosthetic heart valves: Objective Performance Criteria versus randomized clinical trial. Ann Thorac Surg 2006, 82:776-780.
15. Rose E.A., Moskowitz A.J., Packer M., et al. The REMATCH trial: rationale, design, and end points. Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure. Ann Thorac Surg 1999, 67:723-730.
16. Miller L.W., Pagani F.D., Russell S.D., et al. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med 2007, 357:885-896.
17. Pagani F.D., Miller L.W., Russell S.D., et al. Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. J Am Coll Cardiol 2009, 54:312-321.
18. Dowling R.D., Park S.J., Pagani F.D., et al. HeartMate VE LVAS design enhancements and its impact on device reliability. Eur J Cardiothorac Surg 2004, 25:958-963.
19. Slaughter M.S., Rogers J.G., Milano C.A., et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 2009, 361:2241-2251.
20. Esmore D., Spratt P., Larbalestier R., et al. VentrAssist left ventricular assist device: clinical trial results and Clinical Development Plan update. Eur J Cardiothorac Surg 2007, 32:735-744.
21. Wieselthaler G.M., O Driscoll G., Jansz P., et al. Initial clinical experience with a novel left ventricular assist device with a magnetically levitated rotor in a multi-institutional trial. J Heart Lung Transplant 2010.
22. Stevenson L.W., Couper G. On the fledgling field of mechanical circulatory support. J Am Coll Cardiol 2007, 50:748-751.
23. Stevenson L.W., Pagani F.D., Young J.B., et al. INTERMACS profiles of advanced heart failure: the current picture. J Heart Lung Transplant 2009, 28:535-541.
24. Kirklin J.K., Naftel D.C., Kormos R.L., et al. Second INTERMACS annual report: more than 1,000 primary left ventricular assist device implants. J Heart Lung Transplant 2010, 29:1-10.
25. Levy W.C., Mozaffarian D., Linker D.T., et al. The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation 2006, 113:1424-1433.
26. Lund L.H., Aaronson K.D., Mancini D.M. Validation of peak exercise oxygen consumption and the Heart Failure Survival Score for serial risk stratification in advanced heart failure. Am J Cardiol 2005, 95:734-741.
27. Matthews J.C., Koelling T.M., Pagani F.D., et al. The right ventricular failure risk score a pre-operative tool for assessing the risk of right ventricular failure in left ventricular assist device candidates. J Am Coll Cardiol 2008, 51:2163-2172.
28. Lietz K., Long J.W., Kfoury A.G., et al. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. Circulation 2007, 116:497-505.
29. Ketchum E.S., Moorman A.J., Fishbein D.P., et al. Predictive value of the Seattle Heart Failure Model in patients undergoing left ventricular assist device placement. J Heart Lung Transplant 2010, 29:1021-1025.
30. Pitt B., Zannad F., Remme W.J., et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999, 341:709-717.
31. Packer M., Fowler M.B., Roecker E.B., et al. Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study. Circulation 2002, 106:2194-2199.
32. Bristow M.R., Saxon L.A., Boehmer J., et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004, 350:2140-2150.
33. Pitt B., Remme W., Zannad F., et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 2003, 348:1309-1321.
34. Cleland J.G., Daubert J.C., Erdmann E., et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005, 352:1539-1549.
35. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999, 353:2001-2007.
36. Kadish A., Dyer A., Daubert J.P., et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 2004, 350:2151-2158.